Pfizer to Lower Drug Prices Following Talk With Trump
NBC4 Washington -

Following a discussion with President Donald Trump, pharmaceutical giant Pfizer announced Tuesday that it would roll back planned drug price increases for July, NBC News reported. 

The president said he met with Pfizer CEO Ian Read, as well as U.S. Department of Health and Human Services Secretary Alex Azar to discuss Trump's "drug pricing blueprint" and came away with a vow from the company to roll back price increases "so American patients don’t pay more." Facebook Fined Over Cambridge...

Loading...

Related Articles